[go: up one dir, main page]

DE60317799D1 - Antimikrobielle zusammensetzung und anwendungsverfahren - Google Patents

Antimikrobielle zusammensetzung und anwendungsverfahren

Info

Publication number
DE60317799D1
DE60317799D1 DE60317799T DE60317799T DE60317799D1 DE 60317799 D1 DE60317799 D1 DE 60317799D1 DE 60317799 T DE60317799 T DE 60317799T DE 60317799 T DE60317799 T DE 60317799T DE 60317799 D1 DE60317799 D1 DE 60317799D1
Authority
DE
Germany
Prior art keywords
antimicrobial composition
antimicrobial
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60317799T
Other languages
English (en)
Other versions
DE60317799T2 (de
Inventor
Stephen R Smith
Stuart J Richie
Guopeng Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEOVA TECHNOLOGIES Inc
Original Assignee
NEOVA TECHNOLOGIES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEOVA TECHNOLOGIES Inc filed Critical NEOVA TECHNOLOGIES Inc
Application granted granted Critical
Publication of DE60317799D1 publication Critical patent/DE60317799D1/de
Publication of DE60317799T2 publication Critical patent/DE60317799T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60317799T 2002-09-18 2003-09-18 Antimikrobielle zusammensetzung und anwendungsverfahren Expired - Lifetime DE60317799T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002404356A CA2404356A1 (en) 2002-09-18 2002-09-18 Gram-positive antibacterial composition and method for use
CA2404356 2002-09-18
PCT/CA2003/001359 WO2004026334A1 (en) 2002-09-18 2003-09-18 Antimicrobial composition and method for use

Publications (2)

Publication Number Publication Date
DE60317799D1 true DE60317799D1 (de) 2008-01-10
DE60317799T2 DE60317799T2 (de) 2008-11-20

Family

ID=32000084

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60317799T Expired - Lifetime DE60317799T2 (de) 2002-09-18 2003-09-18 Antimikrobielle zusammensetzung und anwendungsverfahren

Country Status (10)

Country Link
US (2) US20050266050A1 (de)
EP (2) EP1902724A3 (de)
JP (1) JP4664678B2 (de)
AU (1) AU2003266058A1 (de)
BR (1) BRPI0314118B1 (de)
CA (2) CA2404356A1 (de)
DE (1) DE60317799T2 (de)
DK (1) DK1539224T3 (de)
ES (1) ES2298614T3 (de)
WO (1) WO2004026334A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI276682B (en) * 2001-11-16 2007-03-21 Mitsubishi Chem Corp Substrate surface cleaning liquid mediums and cleaning method
US20070258996A1 (en) * 2005-12-23 2007-11-08 The Sterilex Corporation Antimicrobial compositions
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
ITMI20060678A1 (it) * 2006-04-06 2007-10-07 Sanofi Aventis Otc S P A Composto peptidico ad attivita' b iologica sua preparazione e sue applicazioni
AU2008319177B2 (en) 2007-07-20 2012-07-05 Regents Of The University Of Minnesota Lantibiotics from bifidobacterium longum and uses thereof
CN102858968B (zh) 2010-02-25 2015-07-01 诺维信公司 溶菌酶的变体及编码该变体的多核苷酸
WO2012035103A1 (en) 2010-09-16 2012-03-22 Novozymes A/S Lysozymes
ITMI20111555A1 (it) * 2011-08-29 2013-03-01 Cevolani Daniele S R L Mangimi e composizioni per uso veterinario e/o zootecnico
AU2012342456B2 (en) 2011-11-25 2016-11-24 Novozymes A/S Polypeptides having lysozyme activity and polynucleotides encoding same
ES2582802T3 (es) 2012-01-23 2016-09-15 Morphosys Ag Uso de lisozima como marcador
RU2504386C1 (ru) * 2012-12-18 2014-01-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Препарат для профилактики диарей у новорожденных телят
ES3038023T3 (en) 2014-11-04 2025-10-09 Novozymes As Polypeptides having serine protease activity and polynucleotides encoding same and their application in animal feed
WO2017001703A1 (en) 2015-07-02 2017-01-05 Novozymes A/S Methods of improving animal performance
US11685911B2 (en) 2016-02-16 2023-06-27 Monaghan Mushroom S Group Fungal polypeptides having lysozyme activity
ES2915100T3 (es) 2017-01-04 2022-06-20 Novozymes As Lisozima microbiana para su uso en el tratamiento del síndrome del intestino irritable o de la enfermedad inflamatoria intestinal
CN110621779B (zh) 2017-05-12 2024-05-14 诺维信公司 具有溶菌酶活性的多肽、编码其的多核苷酸以及其用途和组合物
AU2018300062A1 (en) * 2017-07-10 2020-01-30 Contrafect Corporation Blood component potentiation of lytic protein anti-bacterial activity and methods and uses thereof
WO2019018368A1 (en) * 2017-07-17 2019-01-24 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. ANTIBACTERIAL METHODS AND ASSOCIATED KITS
AU2018322865B2 (en) 2017-09-01 2023-11-09 Novozymes A/S Animal feed additives comprising polypeptide having protease activity and uses thereof
JP7515396B2 (ja) 2017-09-01 2024-07-12 ノボザイムス アクティーゼルスカブ プロテアーゼ活性を有するポリペプチドを含む動物用飼料添加物及びその使用
US20210037856A1 (en) 2018-03-05 2021-02-11 Novozymes A/S Ruminant Feed Composition Comprising A Muramidase
EP3766361B1 (de) 2018-03-16 2023-11-01 Ajinomoto Co., Inc. Tierfutterzusatz und tierfutter
EP3843552A1 (de) 2018-08-31 2021-07-07 Novozymes A/S Polypeptide mit proteaseaktivität und polynukleotide zur codierung davon
US20210337828A1 (en) 2018-09-11 2021-11-04 Dsm Ip Assets B.V. Animal feed composition and use thereof
MX2021002870A (es) 2018-09-11 2021-09-08 Dsm Ip Assets Bv Composicion de alimento animal y uso de la misma.
EP3849338A2 (de) 2018-09-11 2021-07-21 DSM IP Assets B.V. Tierfutterzusammensetzungen mit muramidase und deren verwendung
AU2019339736B2 (en) 2018-09-11 2025-06-19 Novonesis Animal Biosolutions Ag Animal feed composition and use thereof
US20220046954A1 (en) 2018-09-11 2022-02-17 Dsm Ip Assets B.V. Animal feed composition and use thereof
CN112752514A (zh) 2018-09-17 2021-05-04 帝斯曼知识产权资产管理有限公司 动物饲料组合物及其用途
BR112021017999A2 (pt) 2019-03-11 2022-01-25 Novozymes As Métodos para aperfeiçoar a razão de conversão alimentar de uma ração animal, para gerar um prebiótico in situ em uma ração animal à base de milho, para diminuir a fração de milho insolúvel em uma ração animal à base de milho, para aperfeiçoar a saúde intestinal de um animal monogástrico, para causar um efeito butirogênico em um animal monogástrico, para a produção in situ de prebióticos em animais monogástricos, ração animal enriquecida com enzima, e, uso de glucuronoxilano hidrolase gh30 para preparar uma ração animal enriquecida com enzima
CN110692850A (zh) * 2019-10-09 2020-01-17 北京首朗生物科技有限公司 一种乙醇梭菌蛋白在禽类饲料中的应用
MX2022014213A (es) * 2020-05-14 2022-12-07 Zivo Bioscience Inc Uso del modulador tlr4 en el tratamiento de la coccidiosis.
WO2022175262A1 (en) * 2021-02-16 2022-08-25 Dsm Ip Assets B.V. Methods for reducing pathogenic e coli by selective feed additive intervention comprising enzymes such as muramidase
US20240156921A1 (en) 2021-03-16 2024-05-16 Dsm Ip Assets B.V. Animal feed composition and use thereof
CN115990246A (zh) * 2021-10-19 2023-04-21 上海高科生物工程有限公司 一种兼具抗幽门螺旋杆菌和胃黏膜修复功能的蛋白组合物及其应用
CN115105490B (zh) * 2022-06-16 2024-01-30 青岛农业大学 一种抑制产气荚膜梭菌的植物精油组合物及应用
PE20251854A1 (es) 2022-12-08 2025-07-22 Novozymes As Polipeptido que tiene actividad de lisozima y polinucleotidos que lo codifican
KR102834788B1 (ko) * 2022-12-16 2025-07-18 박수민 고중량 유정란의 생산이 가능한 국화꽃을 주성분으로 하는 산란계용 사료 조성물 및 이를 이용한 고중량 유정란
AU2024325051A1 (en) 2023-08-15 2026-01-29 Novozymes A/S Polypeptides having alkaline phosphatase activity for animal feed

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073884A (en) * 1976-09-27 1978-02-14 W. R. Grace & Co. Promotion of feed efficiency
JPH0647550B2 (ja) * 1985-12-18 1994-06-22 日本化薬株式会社 抗ウイルス剤
US4968493A (en) * 1986-06-30 1990-11-06 American Cyanamid Company Method for controlling chronic respiratory disease, fowl cholera and necrotic enteritis in avian species
US5356625A (en) * 1986-08-28 1994-10-18 Enzacor Properties Limited Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals
US5597564A (en) * 1986-08-28 1997-01-28 Enzacor Properties Limited Method of administering a microgranular preparation to the intestinal region of animals
US5314962A (en) * 1987-04-07 1994-05-24 Mitsubishi Petrochemical Company Limited ABA type block copolymers
US5314692A (en) * 1987-08-24 1994-05-24 Cultor Ltd. Enzyme premix for feed and method
US5135910A (en) * 1988-06-22 1992-08-04 The Public Health Research Institute Of The City Of New York Nisin compositions for use as enhanced, broad range bactericides
DE3841152A1 (de) * 1988-12-07 1990-06-13 Hoechst Ag Verwendung von bakterienlysierendem enzymprodukt als zusatzstoff zur verbesserung der futterverwertung in der tierproduktion
US5458876A (en) * 1988-12-21 1995-10-17 Haarman & Reimer Corp. Control of microbial growth with lantibiotic/lysozyme formulations
US5573797A (en) * 1989-02-21 1996-11-12 Viskase Corporation Film and method for surface treatment of foodstuffs with antimicrobial compositions
US5573800A (en) * 1989-02-21 1996-11-12 Viskase Corporation Antimicrobial composition for surface treatment of foodstuffs
US5573801A (en) * 1989-02-21 1996-11-12 Viskase Corporation Surface treatment of foodstuffs with antimicrobial compositions
DE69002024T2 (de) * 1989-02-25 1993-11-18 Morinaga Milk Industry Co Ltd Bioaktive Laktoferrin Derivate.
DE69014030T3 (de) * 1989-09-05 1999-06-24 Ajinomoto Co., Inc., Tokio/Tokyo Mittel für die Verhütung und Behandlung von Diarrhöe.
US5041236A (en) * 1989-10-27 1991-08-20 The Procter & Gamble Company Antimicrobial methods and compositions employing certain lysozymes and endoglycosidases
US5736139A (en) * 1989-10-31 1998-04-07 Ochidian Pharmaceuticals, Inc. Treatment of Clostridium difficile induced disease
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A
NZ236795A (en) * 1990-03-13 1992-05-26 Microlife Technics Bacteriocin from lactococcus with molecular weight about 6000 and devices and foods containing it
US5015487A (en) * 1990-04-23 1991-05-14 Haarmann & Reimer Corp. Use of lanthionines for control of post-processing contamination in processed meat
US5043176A (en) * 1990-06-13 1991-08-27 Haarmann & Reimer Corp. Synergistic antimicrobial compositions
EP0466244A1 (de) * 1990-07-13 1992-01-15 Unilever N.V. Zusammensetzungen mit antibakteriellen Eigenschaften und Verwendung derselben zum Verhindern des Wachstums von Mikroorganismen z.B. Listeria Bakterien
US5902579A (en) * 1991-08-05 1999-05-11 Bio-Technical Resources Natamycin-containing streptomyces biomass and its use in animal feed
US5342612A (en) * 1991-12-20 1994-08-30 American Cyanamid Company Compositions for the treatment of mammalian diseases
JPH06145066A (ja) * 1992-02-15 1994-05-24 Imuno Japan:Kk 化学療法剤の作用増強並びに感染症予防及び治療用の医薬組 成物
GB2283020B (en) * 1992-05-20 1996-05-01 Secr Defence Clostridium perfringens vaccines
FI102807B1 (fi) * 1994-08-25 1999-02-26 Valio Oy Lactobacillus rhamnosuksen käyttö elintarviketeollisuudessa klostridien estoon
IES70514B2 (en) * 1995-04-12 1996-12-11 Teagasc Agric Food Dev Authori Bacteriocins
AU730501B2 (en) * 1996-04-23 2001-03-08 Novozymes A/S Animal feed additives
US5741489A (en) * 1996-05-24 1998-04-21 Anitox Corporation Passively administered antibody that enhances feed conversion efficiency
JP2001503970A (ja) * 1996-09-05 2001-03-27 ガヴァナーズ オブ ジ ユニヴァーシティ オブ アルバータ 新規なバクテリオシン、輸送とベクター系及びそれの使用方法
US5932469A (en) * 1997-06-10 1999-08-03 University Of Florida Antimicrobial polypeptide, nucleic acid, and methods of use
FR2765078B1 (fr) * 1997-06-27 1999-09-17 Guyomarc H Nutrition Animale Procede d'amelioration de l'efficacite d'un probiotique, preparation d'additifs alimentaires et aliments pour animaux la contenant
SE511025C2 (sv) * 1997-10-03 1999-07-26 Probi Ab Foderprodukt för häst omfattande Lactobacillus plantarum JI:1 samt Lactobacillus plantarum JI:1 och användning därav
US20020037260A1 (en) * 1997-10-16 2002-03-28 Budny John A. Compositions for treating biofilm
CZ287989B6 (cs) * 1998-03-20 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě infekčních gastroenteritid prasat
US6033705A (en) * 1998-07-08 2000-03-07 Isaacs; Charles E. Method for treating foodstuffs to reduce or prevent microbial activity
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
AU764855B2 (en) * 1998-12-15 2003-09-04 Rhodia Inc. Broad-range antibacterial composition
JP2000270858A (ja) * 1999-03-26 2000-10-03 Taiyo Kagaku Co Ltd リゾチーム糖複合体
US20020001582A1 (en) * 1999-04-21 2002-01-03 Charter Edward A. Methods and compositions for inhibiting microbial growth
US6451365B1 (en) * 2000-07-14 2002-09-17 Rhodia Inc. Antibacterial composition for control of gram positive bacteria in food applications
US6280725B1 (en) * 2000-01-18 2001-08-28 Lipton, Division Of Conopco, Inc. Compositions and methods for inhibiting the growth of fungi
US6287617B1 (en) * 2000-02-02 2001-09-11 Rhodia Inc. Gram negative antibacterial composition
GB2379166A (en) 2002-10-22 2003-03-05 Dsm Nv Animal feed

Also Published As

Publication number Publication date
DE60317799T2 (de) 2008-11-20
CA2498143A1 (en) 2004-04-01
DK1539224T3 (da) 2008-03-31
JP2005539070A (ja) 2005-12-22
US20050266050A1 (en) 2005-12-01
BR0314118A (pt) 2005-07-12
BRPI0314118B1 (pt) 2016-05-10
CA2404356A1 (en) 2004-03-18
EP1539224A1 (de) 2005-06-15
US20110014178A1 (en) 2011-01-20
EP1902724A3 (de) 2008-07-02
EP1902724A2 (de) 2008-03-26
ES2298614T3 (es) 2008-05-16
WO2004026334A1 (en) 2004-04-01
CA2498143C (en) 2012-11-06
AU2003266058A1 (en) 2004-04-08
EP1539224B1 (de) 2007-11-28
JP4664678B2 (ja) 2011-04-06

Similar Documents

Publication Publication Date Title
DE60317799D1 (de) Antimikrobielle zusammensetzung und anwendungsverfahren
ATE410421T1 (de) P38 inhibitor und anwendungsverfahren dafür
DE60207627D1 (de) Überzug und Überzugszusammensetzung
DE602004005753D1 (de) Kombinationen von harzzusammensetzungen und verwendungsverfahren dafür
EP1298180A4 (de) Hydrophobe und lipophobe zusammensetzung
EP1512408A4 (de) Antibakterielles mittel und antibakterielle zusammensetzung
AU2003259735A8 (en) Small-mer compositions and methods of use
DE602004022571D1 (de) Menschliche epo-mimetische kern-mimetikörper, zusammensetzungen, verfahren und anwendungen
EP1512396A4 (de) Hemmer gegen aktivierung von ap-1 und nfat
EP1680535A4 (de) Galvanisierzusammensetzungen und galvanisierverfahren
DE60231927D1 (de) Reibungsreduzierende Zusammensetzung und zugehöriges Verfahren
DE60216254D1 (de) Acrylkautschukzusammensetzung und vulkanisat
EP1476159A4 (de) Zusammensetzungen und formulierungen von 9- nitrocamptothecin-polymorphen und verwendungsverfahren dafür
DE60334292D1 (de) Ylenverbundemulsionszusammensetzung und verwendung davon
IL166608A0 (en) Anti-microbial compositions and methods of using same
DE60334131D1 (de) Acrylkautschukzusammensetzung und vernetztes objekt
AU2003299441A8 (en) Nf-hev compositions and methods of use
DE60223576D1 (de) Hautbehandlungszusammensetzung
EP1455841A4 (de) Osteopontin-verwandte zusammensetzungen und verfahren
DE60322926D1 (de) Photopolymerisierbare zusammensetzung und verwendung davon
EP1688126A4 (de) Parakeratose-hemmer und topische zusammensetzung für die haut
EP1740120A4 (de) Langzeitformulierungen von naltrexon und anwendungsverfahren
DE60238174D1 (de) Fluoropolymere und Herstellungs- und Verwendungsverfahren
GB0324523D0 (en) Compositions and methods of treatment
EP1578348A4 (de) Formulierung mit bioaktiven mitteln und verwendungsverfahren dafür

Legal Events

Date Code Title Description
8364 No opposition during term of opposition